Attralus is a Biotech company based in South San Francisco, Country (or null). It has raised $201M in total funding. Latest round: Series B.
Attralus funding overview
Attralus is a Biotech company based in South San Francisco, Country (or null). Attralus has raised $201M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in February 2024. The round record for Attralus runs through 2024; nothing later has been disclosed. Investors on record include venBio Partners, Alpha Wave Ventures, Bristol Myers Squibb, 4BIO Capital, Abingworth, Logos Capital and 5 others. 11 distinct backers are named across the disclosed rounds.
Attralus at a glance
Total raised
$201M
Latest round
Series B
Latest round date
February 2024
Industry
Biotech
Headquarters
South San Francisco, Country (or null)
Notable investors
venBio Partners, Alpha Wave Ventures, Bristol Myers Squibb, 4BIO Capital, Abingworth, Logos Capital, Vivo Capital, Sarissa Capital
Frequently asked about Attralus funding
How much has Attralus raised?
Attralus has raised $201M in total disclosed funding across the rounds on record.
Who has invested in Attralus?
venBio Partners, Alpha Wave Ventures, Bristol Myers Squibb, 4BIO Capital, Abingworth, Logos Capital are named among the investors backing Attralus.
What was the latest Attralus funding round?
The most recent disclosed round is a Series B, announced in February 2024.
Where is Attralus based?
Attralus is based in South San Francisco, Country (or null).
What sector does Attralus operate in?
Attralus is tracked under Biotech from South San Francisco, Country (or null), with $201M in disclosed funding.
When did Attralus last raise?
The last disclosed Attralus round closed in February 2024 at Series B.
Every Attralus figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in South San Francisco at a similar stage.
